Nancy Kohl

Nancy Kohl has over 30 years of experience in the field of biotechnology. Nancy began their career in 1987 as Senior Director of Oncology Research at Merck & Co, Inc. In 2009, they became a Consultant and Adjunct Faculty at Emmanuel College. In 2010, they were appointed Head of Research at the Center for Novel Experimental Therapeutics at the Dana Farber Cancer Institute. In 2013, they were promoted to Vice President of Biology at Blueprint Medicines, and in 2021 they were appointed Interim Head of Pre Clinical Development at Unnatural Products.

Nancy Kohl received their Ph.D. in Biochemistry from Columbia University between 1981 and 1986.